VKH
SGYP

Virtu KCG Holdings’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Virtu KCG Holdings’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$1.06M Buy
+237,429
New +$979K 0.03% 540
2017
Q1 		– Sell
-73,988
Closed -$451K – 4047
2016
Q4 		$451K Buy
+73,988
New +$387K 0.01% 1626

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu KCG Holdings's SGYP Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2017: 237,429 shares worth $1.06M. The stake represents 0.03% of the portfolio and ranks #540 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in SGYP as recently as Q4 2016.

Virtu KCG Holdings first reported a position in SGYP in Q4 2016 and has held it in 2 quarters since. 146 funds tracked by Wall St. Rank hold SGYP as of Q2 2017.

  • Virtu KCG Holdings held 237,429 shares of Synergy Pharmaceuticals, Inc Common Stock worth $1.06M as of Q2 2017.
  • Synergy Pharmaceuticals, Inc Common Stock was a new Virtu KCG Holdings position in Q2 2017.
  • Synergy Pharmaceuticals, Inc Common Stock made up 0.03% of Virtu KCG Holdings's portfolio in Q2 2017, its #540 holding.
  • Virtu KCG Holdings first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2016 and has held it in 2 quarters since.
  • 146 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.